Search

everythinglearnresearchcommunity

for

Search:↓

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

Finasteride's effectiveness for frontal fibrosing alopecia is uncertain.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Alopecia causes hair loss and should be treated early, especially scarring types where hair cannot regrow.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Minoxidil may help with hair regrowth and disease stabilization in scarring alopecia, but side effects vary, needing more research for consistent safety and effectiveness.

Biopsies matched initial diagnoses in 76.6% of black women with alopecia and led to treatment changes in 44% of cases.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

The authors suggest a method for hair transplantation in fibrosing alopecia pattern distribution to improve treatment outcomes and cover bald areas.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.

Hair follicle bumps with stem cells might contribute to permanent hair loss by getting disconnected due to scarring.

A 5-year-old boy was diagnosed with congenital triangular alopecia, a type of hair loss without skin changes, usually starting between ages 2-5, with no specific treatment.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

Chemical relaxers may cause scarring alopecia in black women.

A condition called Central Centrifugal Cicatricial Alopecia causes hair loss and scalp burning in middle-aged African women, and it's treated with various medications, hair transplants, and non-drug methods like wigs.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Scalp biopsies greatly improved diagnosis and treatment for Black women with unclear alopecia.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.